Mental Health, Fatty Liver, and Resistant Hypertension

This week's topics include treating resistant hypertension, gabapentanoids and the risk of self harm, risk for depression after diagnosis of a medical condition, and fatty liver and pregnancy.

Program notes:

0:35 Depression after medical condition diagnosis

1:36 Any of a number of medical conditions

2:37 A much lower risk in comparison group

3:37 Major depressive disorder could be number one cause of YLL

4:01 Fatty liver and pregnancy outcomes

5:01 Matched to those with obesity or T2D

6:01 Screening general population not indicated

7:00 Gabapentanoids and risk of self harm

8:01 Rates of self harm variable 

9:04 Use has increased fourfold

10:00 Treatment of resistant hypertension

11:01 Spironolactone or amiloride

12:33 End